Skip to content
Uveitis

Panophthalmitis

Panophthalmitis is a rapidly progressive purulent infection in which inflammation spreads to all structures of the eye (choroid, retina, vitreous, aqueous humor, cornea, and sclera) as well as the periorbital tissues. The term originates from Latin “pan-” (all), “ophthalmo-” (eye), and “-itis” (inflammation). Simply put, it is endophthalmitis accompanied by orbital cellulitis.

Infection routes are broadly classified as exogenous and endogenous.

  • Exogenous: Caused by penetrating ocular trauma, postoperative infection after cataract surgery or vitrectomy, bleb-related infection, intravitreal injection, or spread from corneal ulcer. When caused by vitrectomy or intravitreal injection, onset is rapid and panophthalmitis is more likely.
  • Endogenous: Occurs when bacteria are hematogenously disseminated into the eye from an infectious focus in another organ. Liver abscess is the most common primary focus, followed by urinary tract infection, lung abscess, endocarditis, and meningitis. Endogenous cases account for only 2–8% of all endophthalmitis.

According to a 2018 report, among cases that progressed from endophthalmitis to panophthalmitis, the most common cause was ocular trauma (39.9%), followed by microbial keratitis (27.7%), endogenous causes (21.2%), and post-cataract surgery (9.1%). No racial or sex predilection has been reported. Over 80% of cases are unilateral, but in endogenous cases, the right eye is affected approximately twice as often as the left eye7). This is thought to be because blood flow from the right carotid artery to the right eye is more direct7).

If treatment is delayed, it can lead to devastating outcomes such as phthisis bulbi, permanent vision loss, as well as cavernous sinus thrombosis, meningitis, encephalitis, sepsis, and death.

Q What is the difference between panophthalmitis and endophthalmitis?
A

Endophthalmitis is inflammation within the eye primarily involving the vitreous and aqueous humor. Panophthalmitis refers to a condition where inflammation extends beyond this to include the sclera and periorbital tissues. It is accompanied by eyelid edema, proptosis, and restricted eye movement, presenting with clinical features of orbital cellulitis, which distinguishes it from endophthalmitis.

Panophthalmitis progresses rapidly and presents with the following symptoms.

  • Severe eye pain: This is the most prominent symptom and worsens with eye movement.
  • Rapid vision loss: In many cases, vision decreases to light perception or worse. It may progress to no light perception within hours to days after onset7).
  • Eyelid swelling and redness: May involve severe swelling that prevents the patient from opening the eye on their own.
  • Fever and chills: In endogenous cases, fever and leukocytosis precede as systemic symptoms of sepsis.

Clinical Findings (Findings Confirmed by Physician Examination)

Section titled “Clinical Findings (Findings Confirmed by Physician Examination)”

Intraocular Findings

Hypopyon and fibrin: Marked anterior chamber inflammation is observed, sometimes accompanied by hyphema7).

Corneal edema and opacity: Severe corneal edema makes it difficult to visualize the fundus.

Vitreous opacity: Dense diffuse vitreous opacity is observed, often assessable only by ultrasound6).

Retinal detachment and choroidal detachment: Detachment due to exudative changes is visualized on B-scan.

Orbital findings

Proptosis: An important sign indicating inflammation spreading into the orbit 1).

Restricted eye movement: Inflammatory swelling of the extraocular muscles causes partial to complete ophthalmoplegia.

Relative afferent pupillary defect: Indicates progression of optic neuropathy 7).

Conjunctival injection and chemosis: Severe ciliary injection and marked edema are observed.

Systemic findings include fever, leukocytosis, and elevated CRP. An increase in procalcitonin, a serum marker for severe bacterial infection, is also observed. In advanced cases, perforation of the cornea or sclera may occur.

Q How to differentiate orbital cellulitis from panophthalmitis?
A

Both present similar orbital signs, but panophthalmitis is distinguished by the presence of intraocular inflammation such as hypopyon and marked vitreous opacity. If CT or MRI images show scleral thickening, globe deformity, or intraocular abscess formation, panophthalmitis is suggested 6).

The causative microorganisms of panophthalmitis are diverse.

Bacteria:

  • Staphylococcus aureus (including MRSA): Common in nosocomial infections and after surgery. There are reports of panophthalmitis developing from dialysis catheter infection through MRSA bacteremia1).
  • Bacillus cereus: Widely present in soil and the environment, common in intravenous drug users. It has strong tissue-destructive properties due to lecithinase production.
  • Klebsiella pneumoniae: The most important causative agent of endogenous endophthalmitis, often associated with liver abscess. Endophthalmitis is reported to occur in 3–8% of liver abscess cases.
  • Escherichia coli: Causes endogenous panophthalmitis in diabetic patients5). ESBL-producing strains have also been reported.
  • Pseudomonas aeruginosa: Severe cases due to drug-resistant strains are a concern. Infections from contaminated artificial tears have been reported2).
  • Clostridium spp.: Panophthalmitis caused by C. septicum has been strongly associated with colorectal cancer4). It is characterized by rapid tissue necrosis with gas production.

Fungi:

  • Aspergillus and Rhizopus: Occur in immunocompromised individuals or after trauma. Fungal infection is possible even if culture is negative3).
  • Candida: Commonly occurs in patients using IVH catheters or indwelling catheters. Endophthalmitis develops in 15–30% of patients with candidemia.

Others:

  • Treponema pallidum: Panophthalmitis is a rare manifestation, but panophthalmitis with hypopyon has been reported in HIV-coinfected patients9).
  • Diabetes: the most common underlying disease5)7). Weakening of the blood-retinal barrier promotes infection7).
  • Immunodeficiency/immunosuppression: organ transplantation, HIV/AIDS, malignant tumors, chemotherapy
  • Indwelling catheters/venous access: bacteremia from dialysis tunnel catheters is an important source of infection1).
  • Intravenous drug use (IVDU)
  • Penetrating ocular trauma / intraocular surgery
  • Endocarditis / bacteremia
  • History of invasive procedures such as dental treatment or intestinal surgery: There is a report of odontogenic maxillary sinusitis leading to panophthalmitis via an orbital floor defect8).
Q Why are people with diabetes more prone to panophthalmitis?
A

In diabetes, the permeability of the blood-retinal barrier is increased, creating an environment where bacteria can easily reach the eye via the bloodstream7). Additionally, reduced immune function weakens the ability to fight infection, so once an infection occurs, it tends to progress rapidly.

The diagnosis of panophthalmitis is primarily based on clinical findings. A detailed medical history (history of eye surgery, trauma, systemic infection, drug use, and travel history) is important.

  • B-mode ultrasonography: Evaluates vitreous opacities (increased echogenicity), exudative retinal detachment, choroidal thickening, scleral thickening (“T-sign”), and sub-Tenon’s fluid 6). It is particularly useful when the fundus is not visible due to corneal opacity.
  • CT scan: Evaluates globe deformity, scleral irregularity, orbital soft tissue swelling, and preseptal/postseptal edema 1). It is also used to rule out cavernous sinus thrombosis.
  • MRI: With excellent soft tissue resolution, it allows detailed evaluation of inflammatory thickening of the sclera, inflammatory changes in orbital fat, and extension to the optic nerve or cavernous sinus 6). Diffusion-weighted imaging (DWI) is useful for identifying abscesses and assessing treatment response 6).
SpecimenTest MethodNotes
Aqueous humor / Vitreous fluidSmear / Culture / PCREssential for definitive diagnosis
BloodCulturePositive rate approximately 56%
UrineCultureSearch for infection focus
  • Electroretinography (ERG) is used to evaluate retinal function.
  • If endogenous infection is suspected, identify the infection focus using blood culture, urine culture, transesophageal echocardiography, whole-body CT, PET-CT, etc.7).
  • Measurement of β-D-glucan levels is useful for detecting invasive fungal infections.7).

Differentiation from orbital cellulitis and scleritis is important. It may be misdiagnosed as acute angle-closure glaucoma.5) If it worsens under steroid treatment, suspect fungal infection.3).

Panophthalmitis is an ophthalmic emergency requiring rapid multidisciplinary management.

If the causative organism is unknown, broad-spectrum antibiotics should be started empirically.

  • Intravitreal injection: Vancomycin 1.0 mg/0.1 mL + ceftazidime 2.0 mg/0.1 mL (off-label). Covers both gram-positive and gram-negative bacteria1).
  • Systemic administration: Broad-spectrum drugs such as fourth-generation cephems (cefozopran) are given intravenously. Carbapenems (Tienam 0.5–1.0 g per dose, twice daily) are also used.
  • Frequent eye drops: Vancomycin eye drops (10 mg/mL), ceftazidime eye drops (20 mg/mL), and aminoglycoside eye drops are administered every hour.

Once the causative organism is identified, the drug is selected based on susceptibility testing. The treatment duration is approximately 3 weeks for uncomplicated bacteremia and 6–8 weeks when metastatic infection is present1).

  • Vitrectomy: Performed when drug therapy is poorly responsive. Vitrectomy and intravitreal antibiotic perfusion (vancomycin 20 μg/mL, ceftazidime 40 μg/mL) are performed. Combined with capsular bag irrigation and posterior capsulotomy, and IOL removal if necessary. However, in panophthalmitis, infection is not confined to the vitreous, so the therapeutic effect of vitrectomy is limited7).
  • Evisceration: Indicated when infection is uncontrolled despite antibiotics, or in cases with no light perception5). If the sclera is thin or necrotic, primary implant placement carries a high risk of extrusion5).
  • Enucleation: The most definitive method for removing the source of infection7). Performed when orbital cellulitis persists or is accompanied by orbital abscess.
Q Can the eye be preserved in panophthalmitis?
A

There are reports that combined multiple intravitreal and periocular antibiotic injections with dexamethasone administration achieved eye preservation even in cases with no light perception and scleral abscess5). However, since many cases ultimately require enucleation or evisceration, early multidisciplinary collaboration and aggressive treatment initiation are important.

6. Pathophysiology and Detailed Pathogenesis

Section titled “6. Pathophysiology and Detailed Pathogenesis”

The main route of endogenous panophthalmitis is that microorganisms released from an infectious focus in the body reach the inside of the eye hematogenously through the short posterior ciliary arteries. There are about 20 short posterior ciliary arteries, which enter the eye near the optic nerve entrance and supply the choroid (up to the equator), ciliary processes, and the circle of Zinn-Haller.

When the blood-ocular barrier first breaks down, an infectious focus forms in the choroid. Subsequently, it progresses from choroidal lesions to retinal lesions and vitreous opacities, eventually spreading inflammation to the anterior chamber, sclera, and periorbital area, resulting in panophthalmitis. Bacterial endophthalmitis worsens rapidly within hours, so early-stage findings are rarely captured.

Microorganisms enter the eye through physical disruption of the blood-ocular barrier, such as surgical incisions, perforating wounds, or implants. Microbial toxins propagate the inflammatory response from the vitreous to the entire eye, leading to panophthalmitis. Bacillus cereus and Clostridium species produce potent exotoxins (lecithinase) that can cause rapid tissue necrosis within 48 hours of inoculation.

Clostridium septicum is a Gram-positive anaerobic bacterium that proliferates in environments with low redox potential 4). This condition does not occur in a healthy intestinal tract, but in the presence of colorectal cancer, necrotic tissue within the tumor provides a suitable environment for growth. Therefore, C. septicum infection is an important sign requiring investigation for gastrointestinal malignancies 4).

Diabetes is the most important underlying disease for endogenous endophthalmitis and panophthalmitis. Animal experiments have shown that a diabetic environment increases the permeability of the blood-retinal barrier and promotes the development of endogenous endophthalmitis 7). Hyperglycemia reduces neutrophil function, leading to delayed infection control. In reported cases, HbA1c levels are often markedly poor, ranging from 8.8% to 13.8% 1)3)5).

7. Latest Research and Future Perspectives

Section titled “7. Latest Research and Future Perspectives”

New Therapeutic Drugs for Drug-Resistant Bacteria

Section titled “New Therapeutic Drugs for Drug-Resistant Bacteria”

Panophthalmitis caused by multidrug-resistant and extensively drug-resistant (XDR) gram-negative bacteria is a serious challenge with limited treatment options.

Wang et al. (2023) reported a case of XDR Pseudomonas aeruginosa panophthalmitis due to contaminated artificial tears. This strain, carrying VIM-80 and GES-9 genes, was resistant to almost all antibiotics except piperacillin-tazobactam. The novel siderophore cephalosporin cefiderocol (1.5 g every 8 hours for 14 days) was used, resulting in improvement of orbital cellulitis2).

Cefiderocol utilizes iron to be actively taken up into bacterial cells like a “Trojan horse,” thereby evading resistance due to efflux pumps and porin channel mutations. Currently, it is FDA-approved only for complicated urinary tract infections, but data on intravitreal penetration are scarce, and further research is awaited2).

Treatment Strategies Aiming for Eye Preservation

Section titled “Treatment Strategies Aiming for Eye Preservation”

Chen et al. reported a case of endogenous bacterial panophthalmitis with loss of light perception and scleral abscess, in which enucleation and evisceration were avoided by multiple intravitreal and periocular antibiotic injections combined with dexamethasone5).

This method has not yet been validated by large-scale clinical trials and is not applicable to all cases, but it suggests the possibility of eye preservation through aggressive drug administration.

Azzopardi et al. (2022) reported a case of sterile endogenous panophthalmitis in a patient with diabetes. Blood culture, vitreous culture, and PCR were all negative, but marked inflammation and glycemic abnormalities were observed with CRP 181 mg/L and HbA1c 138 mmol/mol. PET-CT also did not identify any malignancy or infectious focus7).

Even in culture-negative panophthalmitis, it is difficult to completely rule out infection, and continued aggressive antimicrobial therapy is recommended7).


  1. Batista JP, Hamarsha Z, Lew SQ. Endogenous panophthalmitis and eye enucleation secondary to methicillin-resistant Staphylococcus aureus bacteremia: a rare complication of tunneled dialysis catheter use. Cureus. 2023;15(2):e35107.
  2. Wang T, Jain S, Glidai Y, et al. Extensively drug-resistant Pseudomonas aeruginosa panophthalmitis from contaminated artificial tears. IDCases. 2023;33:e01839.
  3. Sun LW, Sassalos TM, Zhang AD. Fungal panophthalmitis presenting as severe posterior scleritis. Am J Ophthalmol Case Rep. 2023;32:101910.
  4. Berlanga Díaz A, Azevedo González-Oliva M, Hervás R, Gili P. Fulminant endogenous panophthalmitis caused by Clostridium septicum infection. Arq Bras Oftalmol. 2023;86(1):71-73.
  5. Hassanin FF, Elkhamary S, Al Thaqib R, Strianese D. A case of Escherichia coli endogenous panophthalmitis and orbital cellulitis with normal workup for primary focus. Cureus. 2021;13(5):e15103.
  6. Sharma V, Sharma R, Tiwari T, Goyal S. MRI findings in endophthalmitis and panophthalmitis. BMJ Case Rep. 2022;15:e246856.
  7. Azzopardi M, Ng B, Chong YJ. Sterile endogenous panophthalmitis with uncontrolled diabetes. BMJ Case Rep. 2022;15:e252875.
  8. Mamikunian G, Ziegler A, Thorpe E. A case of panophthalmitis secondary to odontogenic maxillary sinusitis. Cureus. 2022;14(10):e30801.
  9. Seely M, Deaner JD, Vajzovic L. A unique case of syphilitic hypopyon panophthalmitis. J VitreoRetinal Dis. 2022;6(4):308-311.

Copy the article text and paste it into your preferred AI assistant.